Cargando…
Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019
Patients with pre‐existing liver diseases are considered to have an increased risk of morbidity and mortality from any type of infection, including viruses. The aim of this work was to explore the implications of metabolic dysfunction‐associated fatty liver disease (MAFLD) and nonalcoholic fatty liv...
Autores principales: | Vázquez‐Medina, Martín Uriel, Cerda‐Reyes, Eira, Galeana‐Pavón, Alberto, López‐Luna, Carlos Enrique, Ramírez‐Portillo, Patty Marlen, Ibañez‐Cervantes, Gabriela, Torres‐Vázquez, Julián, Vargas‐De‐León, Cruz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110946/ https://www.ncbi.nlm.nih.gov/pubmed/35438253 http://dx.doi.org/10.1002/hep4.1957 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018) -
Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023) -
Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012) -
Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013) -
Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)